Prostaglandins in Critical Limb Ischaemia

De Gaetano G. Bertelé V. Cerletti C. Mechanism of action and clinical use of prostanoids. In: Dormandy J A Stock G. eds. Critical leg ischaemia: Its pathophysiology and management. Berlin: Springer-Verlag, 1990: 117–43.

Lowe G. D. O. Drugs in cerebral and peripheral arterial disease. Br Med J 1990; 300: 524–28.

Norgren L. Non-surgical treatment of critical limb ischaemia. Eur J Vasc Surg 1990; 4: 449–54.

European Working Group on Critical Leg Ischaemia. Second European Consensus Document on chronic critical leg ischaemic circulation. Circulation 1991; 84: (suppl IV): 1–26.

Nizankowski R. Krolikowski W. Beilatowicz J. Szczeklik A. Prostacyclin for ischaemic ulcers in peripheral arterial disease: A random-assignment, placebo-controlled study. Thromb Res 1985; 37: 21–28.

Negus D. Irving J D Friedgood A. Intra-arterial prostacyclin compared to praxilene in the management of severe lower limb ischaemia: A double-blind trial. J Cardiovasc Surg 1987; 28: 196–99.

Eklund A E Ariksson G. Olsson A. G. A controlled study showing significant short term effect of prostaglandin E1 in healing of ischaemic ulcers of the lower limb in man. Prostaglandins Leukot Med 1982; 8: 265–71.

Schuler J J Flanigan D P Holcroft J W Ursprung J J Mohrland J S Pyke J. Efficacy or prostaglandin E1 in the treatment of lower extremity ischaemic ulcers secondary to peripheral vascular occlusive disease. J Vasc Surg 1984;: 160–70.

Telles G S Campbell W B Wood R F M Collin J. Baird R N Morris P. J. Prostaglandin E1 in severe lower limb ischaemia. A double-blind trial. Br J Surg 1984; 1: 160–70.

Belch J J F McKay A. McArdie B. . Epoprostenol (prostacyclin) and severe arterial disease: A double-blind trial. Lancet 1983; 1: 315–17.

Cronenwett J L Zelenock G B Whitehouse W M Lindenauer S M Graham L M Stanley J. C. Epoprostenol treatment of ischaemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease. Surgery 1986; 100: 369–75.

Sakaguchi S. Prostaglandin E1 intra-arterial infusion therapy in patients with ischaemic ulcer of the extremities. Int Angiol 1984; 3: 39–42.

Böhme H. Brülsaver M. Hätel U. Bollinger A. Kontrollierte Studie zur Wirksamkeit von I.A. PGE, Infusionen bel peripherer arterieller Verschlusskrankheit in Stadium und IV. Vasa 1987; 20 (suppl): 206–208.

Trübestein G. Diehm C. Gruss J D Horsch S. Prostaglandin E1 in advanced occlusive arterial disease: Results of a multicentre study. Vasa 1987; 17 (suppl): 39–43.

Diehm C. Hübsch-Müller C. Stammler F. Intravenöse Prostaglandin E1-Therapie bei Patienten mit peripherer arterieller Verschlusskrankheit (AVK) im Stadium III: Elne doppelbinde, placebo-kontrollierte Studie. In: Heidrich H. Böhme H. Rogatti W. eds. Prostaglandin E1-Wirkungen und therapeutische Wirksamkeit. Heidelberg: Springer-Verlag, 1988: 133–43.

Trübestein G. Von Bary S. Breddin K. . Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease. A controlled randomised multicenter study. Vasa 1989; 28: 44–49.

Balzer K. Bechara G. Bisler H. . Placebokontrollierte, doppel-blinde Multicenterstudie zur Wirksamkeit von lloprost bei der Behandlung ischämischer Ruheschmerzen von Patienten mit peripheren arterielleren Durchblutungsstörungen. Vasa 1987; 20 (suppl): 379–81.

Diehm C. Abri O. Baitsch G. . Lloprost, ein stabiles Prostacyclinderivat bei arterieller Verschlüsskrankheit im Stadium IV. Dtsch Med Wochenschr 1989; 114: 783–88.

Norgren L. Alwmark A. Ängqvist K A . A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb: A Scandinavian–Polish placebo-controlled, randomised multicenter study. Eur J Vasc Surg 1990; 4: 463–6.

Brock F E Abri O. Baitsch G. . Iloprost in der Behandlung ischaemischer Gewebsläsionen bei Diabetikern. Schwirz Med Wochenschr 1990; 20: 1477–82.

Guilmot J L Diot E. , for the French Iloprost Study Group. Treatment of lower limb ischaemia due to atherosclerosis in diabetic, and non diabetic patients with iloprost, a stable analogue of prostacyclin. Results of a French multicentre trial. Drug Invest 1991; 3: 351–59.

UK Severe Limb Ischaemia Study Group. Treatment of limb threatening ischaemia with intravenous iloprost. A randomised double-blind placebo-controlled study. Eur J Vasc Surg 1991; vmr-5: 511–56.